James W. Myatt

Development of a Co-Mediated Rearrangement Reaction

David R. Carbery, Serge Reignier, James W. Myatt et al. · Angewandte Chemie International Edition · 2002 · 37 citations

Natural Sciences, Chemistry, Catalysis +9

Discovery of <i>N</i>-(3-Fluorophenyl)-1-[(4-([(3<i>S</i>)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the First Small Molecule Motilin Receptor Agonist Clinical Candidate

Susan M. Westaway, Samantha L. Brown, Stephen C. M. Fell et al. · Journal of Medicinal Chemistry · 2009 · 29 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Exploration of the biomimetic synthesis of indole-diterpene mycotoxins: an unexpected cascade reaction during the attempted synthesis of emindole SB

J. Stephen Clark, James W. Myatt, Claire Wilson et al. · Chemical Communications · 2003 · 24 citations

Pharmacy, Biochemistry, Medicinal Chemistry +17

Optimization of Sphingosine-1-phosphate-1 Receptor Agonists: Effects of Acidic, Basic, and Zwitterionic Chemotypes on Pharmacokinetic and Pharmacodynamic Profiles

John Skidmore, Jag Heer, Christopher N. Johnson et al. · Journal of Medicinal Chemistry · 2014 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Investigation of the Biomimetic Synthesis of Emindole SB Using a Fluorinated Polyene Cyclisation Precursor

J. Stephen Clark, James W. Myatt, Lee R. Roberts et al. · Synlett · 2005 · 19 citations

Pharmacy, Chemistry, Medicinal Chemistry +15